Patent ReferencesSpherical granules having core and their production Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level Diltiazem controlled release formulation Multiple unit oral pharmaceutical formulations Patent #: 5955104 InventorsAssigneeApplicationNo. 349564 filed on 07/08/1999US Classes:424/458, Containing discrete coated particles pellets, granules, or beads424/457, Sustained or differential release424/459, Organic coatings424/461, Containing polysaccharide (e.g., cellulose sugars, etc.)424/462, Containing solid synthetic polymers424/468, Sustained or differential release type424/494, Cellulose derivatives424/495, Ethyl cellulose424/496, Containing natural gums/resins424/497, Containing solid synthetic polymers514/770, Siliceous or calcareous material (e.g., clay, earth, etc.)514/781, Cellulose or derivative514/782, Natural gum or resin514/951POWDERS, GRANULES OR PARTICLES OF SPECIFIED MESH OR PARTICLE SIZEExaminersPrimary: Spear, James M.International ClassesA61K 009/22A61K 009/54 A61K 009/60 A61K 009/62 Foreign Application Priority Data1996-07-25 DEAbstractA multiple unit oral pharmaceutical dosage form having a plurality of pellets in a water soluble capsule or in a tablet compressed from the pellets, wherein each pellet contains (a) a substantially inert core, (b) an active ingredient layer over the inert core, and containing (i) a pharmacologically active particulate active ingredient, (ii) a nonembedding amount of a binder for adhering the active ingredient over the inert core, and optionally (iii) a pharmaceutically acceptable, inert adjuvant, such as colloidal silica, and (c) a coating over the active ingredient layer for retarding the release of the active ingredient from the active ingredient layer into an aqueous body fluid solvent in situ, the nonembedding amount of the binder is suitably from about 1% wt. to about 10% wt. based on the active ingredient layer, the binder in the active ingredient layer is suitably a mixture of ethylcellulose and shellac, in a weight proportion suitably of from about 1: about 9, to from about 9: about 1, the coating for retarding the release suitably contains from about 70% wt. to about 95% wt. based on the coating, of a substantially water-insoluble, pharmacologically inert, particulate material, and a binder; the pharmacologically inert, particulate material is suitably talcum, and the binder in the active ingredient layer is suitably identical to the binder in the coating.Field of SearchLayered unitary dosage formsContaining discrete coated particles pellets, granules, or beads Organic coatings Containing polysaccharide (e.g., cellulose sugars, etc.) Containing solid synthetic polymers Cellulose derivatives Ethyl cellulose Containing solid synthetic polymers Sustained or differential release Sustained or differential release type Containing natural gums/resins Gelatin Discrete particles in supporting matrix Where particles are granulated | |